Anteotech Ltd
ASX:ADO

Watchlist Manager
Anteotech Ltd Logo
Anteotech Ltd
ASX:ADO
Watchlist
Price: 0.019 AUD 5.56% Market Closed
Market Cap: 52m AUD
Have any thoughts about
Anteotech Ltd?
Write Note

Anteotech Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Anteotech Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Anteotech Ltd
ASX:ADO
Cash & Cash Equivalents
AU$5m
CAGR 3-Years
-38%
CAGR 5-Years
3%
CAGR 10-Years
-3%
Proteomics International Laboratories Ltd
ASX:PIQ
Cash & Cash Equivalents
AU$6.6m
CAGR 3-Years
6%
CAGR 5-Years
34%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Cash & Cash Equivalents
AU$11.2m
CAGR 3-Years
-40%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Cash & Cash Equivalents
AU$703k
CAGR 3-Years
-43%
CAGR 5-Years
-29%
CAGR 10-Years
3%
Genetic Signatures Ltd
ASX:GSS
Cash & Cash Equivalents
AU$36.3m
CAGR 3-Years
6%
CAGR 5-Years
42%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Cash & Cash Equivalents
AU$19m
CAGR 3-Years
29%
CAGR 5-Years
115%
CAGR 10-Years
N/A
No Stocks Found

Anteotech Ltd
Glance View

Market Cap
47.3m AUD
Industry
Life Sciences Tools & Services

AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

ADO Intrinsic Value
0.002 AUD
Overvaluation 91%
Intrinsic Value
Price

See Also

What is Anteotech Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
5m AUD

Based on the financial report for Jun 30, 2024, Anteotech Ltd's Cash & Cash Equivalents amounts to 5m AUD.

What is Anteotech Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-3%

Over the last year, the Cash & Cash Equivalents growth was 85%. The average annual Cash & Cash Equivalents growth rates for Anteotech Ltd have been -38% over the past three years , 3% over the past five years , and -3% over the past ten years .

Back to Top